Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Apr 18,2017
Study Casts Doubt On Autism, Antidepressant Link
    An increased risk of autism among children of women who took antidepressants during pregnancy may actually be the result of maternal mental illnesses, according to new research published Monday (April 17, 2017).     Up to 15 percent of women have depression during pregnancy and antidepressants are a popular treatment choice for those with depression, butRead more
More
Study Casts Doubt On Autism, Antidepressant Link
Apr 18,2017
CD14 Protein Viewed as New Therapeutic Target for IBD
    Inflammatory bowel disease (IBD), characterized by chronic relapsing inflammation of the gut, is a common problem in the industrialized world. However, how IBD develops remains unknown. There is currently no cure and treatment options are costly and limited to alleviating symptoms.         Researchers report in a study ("CD14 Plays a Protective Role in ExperimentalRead more
More
CD14 Protein Viewed as New Therapeutic Target for IBD
Apr 18,2017
Vaccine Targeting Brain Tumors Seems Safe in Study
    Multipronged strategies have been effective approaches in a variety scenarios—combat, sales, end even politics. Medicine is no stranger to these sorts of tactics; however, finding the right efficacious combination to treat disease or improve a patient's quality of life is no simple task. Yet now, investigators at the Duke Cancer Institute may have just hitRead more
More
Apr 17,2017
Gene Silencing Drug Holds Potential to Treat Fatal Neurological Conditions
    Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disease that is characterized by motor neuron loss and that leads to paralysis and death 2–5 years after disease onset.  Nearly all patients with ALS have aggregates of the RNA-binding protein TDP-43 in their brains and spinal cords, and rare mutations in the gene encoding TDP-43Read more
More
Gene Silencing Drug Holds Potential to Treat Fatal Neurological Conditions
Apr 17,2017
Chinese Scientists Discover Compound to Tackle Obesity
    Chinese scientists have extracted a medicinal compound from the natural herb, thunder god vine, which targets cell metabolism and could help tackle obesity.     Celastrol, extracted from thunder god vine, an artemisinin, developed from sweet wormwood, are among five herbal compounds listed by the scientific journal Cell to have the most potential to treat illnesses whereRead more
More
Apr 17,2017
Novel CRISPR Diagnostic Developed for Rapid Disease Detection
    CRISPR is already known for its power as a gene-editing tool that could one day transform how we fight cancer and other life-threatening diseases. But CRISPR's potential is broader than that – and a new study using the technology has shown it can diagnose infections as well.
More
Novel CRISPR Diagnostic Developed for Rapid Disease Detection
Apr 17,2017
Preclinical Pharmacokinetic Study Service
Applying progressive platforms to your development program will help you make informed decisions faster.  Medicilon continues to invest in the latest technologies and philosophies so you have access to innovative solutions utilizing automation, high resolution accurate mass spectrometers.   Pharmacokinetics Studies play a crucial role in the development of molecule. Toward that end, our crossRead more
More
Preclinical Pharmacokinetic Study Service
Apr 14,2017
Organic Chemistry Synthesis of Medicilon
As a leading provider of chemical synthesis services, we provide reference compounds, intermediates, drug candidates, impurities, metabolites, and other small molecule chemicals from milligram to kilogram level (including GMP quality). The chemistry synthesis service comes with weekly updates, final reports and ordered amounts of the compound under strict confidentiality. Final reports contain sufficient information forRead more
More
Organic Chemistry Synthesis of Medicilon
Apr 14,2017
Method to Stop Cancer From Mutating and Spreading Developed by Australian Researchers
 Australian scientists have made a breakthrough in preventing cancer from mutating in the body.     The team from Melbourne's Olivia Newton-John (ONJ) Cancer Wellness and Research Centre have been able to interrupt the body's wound-healing process and lock cancer cells into a "harmless” state before they can mutate and spread.  
More
Method to Stop Cancer From Mutating and Spreading Developed by Australian Researchers
Apr 14,2017
Biomarker May Indicate Presence of Neuro Disease Found in Both the Young and Elderly
    Neurological Diseases that affect the brain or other components of the central nervous system are among the most devastating and complex conditions plaguing mankind today. As populations around the world live longer, diseases related to aging present an unprecedented challenge.     Researchers at the Gladstone Institutes and the University of California, San Francisco (UCSF), say theyRead more
More
Biomarker May Indicate Presence of Neuro Disease Found in Both the Young and Elderly
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->